(1 - 8 von 8
)
Juvabis causes a stir with new antibiotic - Startupticker.ch
www.startupticker.ch
— ... and clearly support our commitment to progressing the clinical development of EBL-1003,” said Dr. Sven Hobbie, CEO of Juvabis. › news
sortiert nach Relevanz / Datum